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Material and Methods: A four-blade dynamic kV collimator 
was developed to track a VOI during CBCT acquisition. The 
system is controlled using a Raspberry Pi computer placed 
within the linac gantry. The current prototype is capable of 
tracking an arbitrary volume defined by the treatment 
planner for subsequent CBCT guidance. During gantry 
rotation, the collimator tracks the VOI with adjustment of 
position and dimension. CBCT image quality was investigated 
as a function of collimator dimension, while maintaining the 
same dose to the VOI, for a 20 cm diameter cylindrical water 
phantom with a 9 mm diameter bone insert centered on 
isocenter. Dose distributions for various anatomical sites 
were modeled using a dynamic BEAMnrc library and 
DOSXYZnrc. The resulting VOI dose distributions were 
compared to full-field distributions to quantify dose 
reduction and localization to the target volume. X-ray tube 
current modulation was investigated in combination with the 
VOI approach, using digitally reconstructed radiographs to 
estimate tube pulse width for each CBCT projection. The 
technique was evaluated in Developer Mode on the linear 
accelerator. 
 
Results: Measurements show contrast increase by a factor of 
1.3 and noise reduction by a factor of 1.7, for VOI CBCT, and 
thus an increase in contrast-to-noise ratio (CNR) by a factor 
of approximately 2.2. Depending upon the anatomical site, 
dose was reduced to 15%–80% of the full field value along the 
central axis plane and down to less than 1% along the axial 
planes. The use of tube current modulation allowed for 
specification of a desired signal-to-noise ratio within 
projection data. For approximately the same dose to the VOI, 
CNR was increased by a factor of 1.2 for tube current-
modulated compared to unmodulated VOI CBCT. 
 
 
 
Conclusion: The VOI CBCT approach allows imaging of a 
planner-defined volume, offering both image quality 
improvement and reduction of imaging dose for the patient. 
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Purpose or Objective: Stereotactic Radiosurgery (SRS) has 
emerged as a treatment of choice for many cancer patients 
with brain metastasis. Most institutes use linac-based 
irradiations with multiple days between imaging and 
irradiation and a subset of patients is treated with 
fractionated SRS. So far, the geometrical uncertainties 
induced by such time intervals have not yet been quantified. 
Therefore, we investigated the growth rates of different 
tumour entities, the effect of oedema and the use of steroids 
on possible tumour shifts to estimate the effect on the 
tumour dose. 
 
Material and Methods: Thirty-six patients were included, 
equally divided over lung-, breast- and melanoma cancer 
patients. Patients receiving systemic cytotoxic treatment 3 
months prior to the diagnostic MRI were excluded, except for 
breast cancer patients on hormonal therapy that started 
more than 6 months prior to the diagnostic MRI. All patients 
had undergone a diagnostic and a radiotherapy planning MRI 
of which the T1w+contrast sequences were registered with 
the planning CT scan for target definition on both scans. 
Consensus was reached for all delineations by two radiation 
oncologists. The median time between the two MRI scans was 
18 days (range 6-54). For all tumour delineations, the 
volume, radius (assuming spherical tumours) and Centre of 
Mass (CoM) were calculated. Growth rates were determined 
from volumetric or radial increase per day between the MRI 
scans. CoM differences between scans served as a measure 
for tumour shifts that can be caused by oedema (-clearance) 
and/ or anisotropic growth. Oedema was scored only if an 
experienced radiologist diagnosed peritumoural oedema on 
the diagnostic MRI. 
 
 
Results: Table 1 shows the results for tumour growth and 
tumour shifts. The highest growth rate in radial increase is 
seen in large melanoma tumours (0.07 mm/day (SD 0.02) , 
p=<0.01). Large heterogeneities in growth rate are seen in 
tumours of both small and large brain metastasis of lung 
cancer patients (small: mean=7%/day, SD=10%, range=0%-
26%, large: mean=3 %/day, SD=6%, range=-1%-15%). In this 
lung group, three patients showed shrinkage; all three 
started steroids after diagnostic MRI. Large tumour shifts 
(mean=1.7 mm) and variability (SD=1.0 mm) were observed in 
the patient group with oedema receiving steroids (whereby 
the growth rate of tumours in these patients was not 
different).  
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Conclusion: Within the limitations of a retrospective study, 
our results show that the growth and shift of brain metastasis 
over time can be significant and may vary over patient 
groups. Given the typical steep dose gradient in SRS 
treatments (>10%/mm), tumour growths and shifts may have 
a significant impact on the tumour dose. Therefore, this 
phenomenon must be considered if the workup and 
treatment of SRS for brain metastasis is encompassing 
multiple days. 
 
OC-0161  
Renal and diaphragmatic interfractional motion in children 
and adults: is there a difference? 
I.W.E.M. Van Dijk
1Academic Medical Center, Department of Radiation 
Therapy, Amsterdam, The Netherlands 
1, S.C. Huijskens1, M.A.J. De Jong1, J. 
Visser1, R. Dávila Fajardo1, C.R.N. Rasch1, T. Alderliesten1, A. 
Bel1 
 
Purpose or Objective: One of the factors determining the 
size of planning target volume (PTV) margins is organ motion. 
Organ motion is comprehensively studied in adults and 
paediatric PTV margins are generally based on these data. 
We hypothesize that adult-based PTV margins are too large 
for paediatric patients because children and adults differ in 
body composition. Our aim was to compare renal and 
diaphragmatic interfractional motion in children with that in 
adults and to investigate the correlation with age and height. 
 
Material and Methods: This single-centre retrospective study 
consisted of 35 children and 35 adults who received 
thoracic/abdominal irradiation between October 2009 and 
December 2014. The mean age of children and adults was 
10.3 years (range 3.1-17.8 years) and 59.9 years (range 34.1-
94.0 years) respectively. Mean height in children and adults 
was 140 cm (range 92-184 cm) and 175 cm (160-203 cm) 
respectively. According to protocol, abdominal and/or 
thoracic Cone Beam CT (CBCT) images were acquired for 
setup verification before radiation delivery. A total of 70 
reference CT (refCT) scans, 350 paediatric CBCTs (mean 10; 
range 5-30) and 476 adult CBCTs (mean 14; range 5-27) were 
available for registration using Elekta XVI software. In order 
to assess renal and diaphragmatic motion, each CBCT was 
registered to its refCT in 2 steps; registration of: 1) the bony 
anatomy (i.e., the vertebral column), and 2) the left kidney, 
right kidney and diaphragm separately. For each individual, 
we assessed organ motion in the left-right (LR), cranio-caudal 
(CC), and anterior-posterior (AP) directions for the left and 
right kidney. Diaphragmatic motion was measured in the CC 
direction only as a surrogate for upper abdominal organ 
motion. Subsequently, for all organs the mean and standard 
deviation of the measurements in all directions were 
calculated and analysed to estimate the group systematic 
error (Σ) and the group random error (σ). The correlations 
between organ motion and age and height were investigated 
using a univariate regression analysis. 
 
Results: Interfractional organ motion in children and adults 
was different; displacements in children were notably smaller 
than in adults. Consequently, the estimated group systematic 
(Σ) and random errors (σ) for the two groups were different 
(Table 1). Within each group, no correlation was found 
between organ motion and age or height. Overall, in the CC 
direction, weak correlations were found between the patient 
random error, and age and height (Figure 1). 
 
 
 
 
 
Conclusion: Our results show that renal and diaphragmatic 
interfractional motion in children tend to be smaller than in 
adults, suggesting that abdominal PTV margins in children 
could be reduced. The difference in organ motion in the two 
groups could not completely be explained by age or height, 
indicating that further research is needed to understand the 
underlying mechanisms. 
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Purpose or Objective: We developed a new liquid fiducial 
marker (BioXmark®) for use in image-guided radiotherapy 
(IGRT). The liquid solidifies into a three dimensional (3D) 
structure after injection into tissue. A good level of marker's 
